Shanghai Fosun Pharmaceutical Group Co Ltd banner

Shanghai Fosun Pharmaceutical Group Co Ltd
SSE:600196

Watchlist Manager
Shanghai Fosun Pharmaceutical Group Co Ltd Logo
Shanghai Fosun Pharmaceutical Group Co Ltd
SSE:600196
Watchlist
Price: 26.57 CNY -1.12% Market Closed
Market Cap: ¥67.9B

Wall Street
Price Targets

Price Targets Summary
Shanghai Fosun Pharmaceutical Group Co Ltd

Wall Street analysts forecast Shanghai Fosun Pharmaceutical Group Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Shanghai Fosun Pharmaceutical Group Co Ltd is 38.05 CNY with a low forecast of 30.3 CNY and a high forecast of 44.52 CNY.

Lowest
Price Target
30.3 CNY
14% Upside
Average
Price Target
38.05 CNY
43% Upside
Highest
Price Target
44.52 CNY
68% Upside
Shanghai Fosun Pharmaceutical Group Co Ltd Competitors:
Price Targets
PAYX
Paychex Inc
36% Upside
THFF
First Financial Corp
-5% Downside

Revenue
Forecast

15% / Year
Past Growth
3% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
15% / Year
Past Growth
3% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

For the last 13 years the compound annual growth rate for Shanghai Fosun Pharmaceutical Group Co Ltd's revenue is 15%. The projected CAGR for the next 3 years is 3%.

Operating Income
Forecast

19% / Year
Past Growth
7% / Year
Estimated Growth
Estimates Accuracy
-17%
Average Miss
19% / Year
Past Growth
7% / Year
Estimated Growth
Estimates Accuracy
-17%
Average Miss

For the last 13 years the compound annual growth rate for Shanghai Fosun Pharmaceutical Group Co Ltd's operating income is 19%. The projected CAGR for the next 3 years is 7%.

Net Income
Forecast

7% / Year
Past Growth
15% / Year
Estimated Growth
Estimates Accuracy
-13%
Average Miss
7% / Year
Past Growth
15% / Year
Estimated Growth
Estimates Accuracy
-13%
Average Miss

For the last 13 years the compound annual growth rate for Shanghai Fosun Pharmaceutical Group Co Ltd's net income is 7%. The projected CAGR for the next 3 years is 15%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Shanghai Fosun Pharmaceutical Group Co Ltd's stock price target?
Price Target
38.05 CNY

According to Wall Street analysts, the average 1-year price target for Shanghai Fosun Pharmaceutical Group Co Ltd is 38.05 CNY with a low forecast of 30.3 CNY and a high forecast of 44.52 CNY.

What is Shanghai Fosun Pharmaceutical Group Co Ltd's Revenue forecast?
Projected CAGR
3%

For the last 13 years the compound annual growth rate for Shanghai Fosun Pharmaceutical Group Co Ltd's revenue is 15%. The projected CAGR for the next 3 years is 3%.

What is Shanghai Fosun Pharmaceutical Group Co Ltd's Operating Income forecast?
Projected CAGR
7%

For the last 13 years the compound annual growth rate for Shanghai Fosun Pharmaceutical Group Co Ltd's operating income is 19%. The projected CAGR for the next 3 years is 7%.

What is Shanghai Fosun Pharmaceutical Group Co Ltd's Net Income forecast?
Projected CAGR
15%

For the last 13 years the compound annual growth rate for Shanghai Fosun Pharmaceutical Group Co Ltd's net income is 7%. The projected CAGR for the next 3 years is 15%.

Back to Top